• share
• favorite_border

• share
• favorite_border

A combination of elevated symptoms of depression along with modifications in a gene responsible for dopamine activity, important to the brain’s pleasure and reward system, appear to influence an addiction to indoor tanning in young, white non-Hispanic women.

• share
• favorite_border

When it comes to buying probiotics, most product labels do not give consumers enough information to make an informed decision, according to a research team led by Georgetown University Medical Center.

• share
• favorite_border

Cancer patients previously excluded and underrepresented in immunotherapy clinical trials, such as African Americans and patients with HIV or viral hepatitis, actually benefit at the same rate as patients tested in the clinical trials, according to a Georgetown-led study to be presented at the 2019 ASCO Annual Meeting in Chicago.

• share
• favorite_border

A survey conducted by Georgetown investigators found a significant knowledge and practice gap among community oncologists in the understanding and usage of genetic testing in determining patients' treatment plans and potential clinical trial outcomes.

• share
• favorite_border

A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million (about 2 percent of the overall costs in the first year). The study by Georgetown Lombardi Comprehensive Cancer Center and National Cancer Institute researchers was published April 24, in JNCI.

• share
• favorite_border

Despite a mandate to help patients make better-informed health care decisions, a ten-year research program established under the Affordable Care Act has funded a relatively small number of studies that examine primary care, the setting where the majority of patients in the U.S. receive treatment.

• share
• favorite_border

A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types.

• share
• favorite_border

The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease.

• share
• favorite_border

• share
• favorite_border

The immunotherapy that has revolutionized treatment of many cancers appear to offer similar benefit to cancer patients living with HIV.

• share
• favorite_border

To the great surprise of cancer researchers in a Georgetown University-led study, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

• share
• favorite_border

• share
• favorite_border

In an article published in Creativity Research Journal, Georgetown researchers address neuro-ethical concerns associated with the increasing use of transcranial electrical stimulation (tES).

• share
• favorite_border

Georgetown Breast Cancer Advocates (GBCA), a volunteer group of survivors and other advocates who support and promote cancer research at Georgetown University, have published an article that underscores ways in which both the scientific and advocacy communities can foster a mutually beneficial collaboration.

• share
• favorite_border

A valuable cache of brain cancer biomedical data, one of only two such large collections in the country, has been made freely available worldwide by researchers at Georgetown Lombardi Comprehensive Cancer Center.

• share
• favorite_border

The Lewy Body Dementia Association has designated Georgetown University Medical Center as a “Research Center of Excellence.”

• share
• favorite_border

Georgetown University and CEPI U.S. – the Coalition for Epidemic Preparedness Innovations U.S. – today announce a new agreement to explore joint cooperative academic and research initiatives.

• share
• favorite_border

Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in aging women — those ages 65 and older, according to research published in JAMA Internal Medicine. The findings could impact mammography screening decisions later in life.

• share
• favorite_border

Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer.